GlassScriptPhysician profile
Douglas L Brown
NPI 1164415956
$2,993.78
in general payments reported to CMS, 2019-2025
19 companies · $448 in 2025
The $448 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,163 · 2020: $42.76 · 2021: $284 · 2022: $424 · 2023: $257 · 2024: $376 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $773.67 | 2019-2025 | Preveleak |
| Medtronic Vascular, INC. | $315.24 | 2019 | |
| Medtronic, INC. | $306.29 | 2022-2025 | Selectsecure, Micra, Aurora Ev-Icd Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.30 | 2019 | |
| Abiomed | $203.42 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $146.42 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Covidien LP | $129.71 | 2019 | |
| Ethicon US, LLC | $124.99 | 2022 | |
| Amgen INC. | $119.27 | 2019-2024 | Repatha |
| Getinge USA Sales, LLC | $109.09 | 2025 | Vasoview Hemopro 2 |
| Haemonetics Corporation | $97.08 | 2021 | |
| Werfen USA LLC | $90.59 | 2021 | |
| Abbott Laboratories | $87.34 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $81.90 | 2022-2024 | Xarelto |
| Chiesi USA, INC. | $60.16 | 2019-2024 | Kengreal, Cleviprex |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $50.01 | 2024 | Bridion |
| Novartis Pharmaceuticals Corporation | $36.93 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $31.87 | 2019 | |
| Terumo Medical Corporation | $18.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.